Matthias Vorgerd Selected Research

1 Rippling muscle disease

4/2003	Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease.
2/2003	Consequences of a novel caveolin-3 mutation in a large German family.
7/2002	Rippling muscle disease in childhood.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthias Vorgerd Research Topics

Disease

21	Muscular Diseases (Myopathy) 06/2021 - 11/2002
11	Myofibrillar Myopathy 06/2021 - 07/2005
6	Glycogen Storage Disease Type V (McArdle's Disease) 01/2018 - 01/2002
6	Muscle Weakness 12/2015 - 11/2002
6	Muscular Dystrophies (Muscular Dystrophy) 05/2015 - 12/2003
4	Inclusion Body Myositis 01/2020 - 09/2011
4	Myositis (Idiopathic Inflammatory Myopathies) 05/2015 - 02/2011
3	Hypertrophy 10/2022 - 07/2002
3	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2022 - 01/2017
3	Disease Progression 08/2021 - 02/2007
3	Neuromuscular Diseases (Neuromuscular Disease) 08/2021 - 02/2011
3	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2017 - 02/2003
3	Myalgia 06/2013 - 04/2010
3	Distal Myopathies (Distal Muscular Dystrophy) 01/2013 - 02/2003
3	Glycogen Storage Disease (Glycogenosis) 08/2005 - 11/2002
3	1 Rippling muscle disease 04/2003 - 07/2002
2	Nervous System Diseases (Neurological Disorders) 08/2021 - 01/2017
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2018 - 01/2017
2	Congenital Structural Myopathies (Centronuclear Myopathy) 01/2018 - 07/2015
2	Myotilinopathy 01/2017 - 07/2005
2	Limb-girdle muscular dystrophy type 2A 01/2017 - 01/2005
2	Miyoshi myopathy 02/2007 - 12/2003
2	type 2B Limb-girdle muscular dystrophy 02/2007 - 12/2003
2	Type 1C Limb-Girdle Muscular Dystrophy 12/2003 - 04/2003
2	Pain (Aches) 07/2003 - 07/2002
1	Parkinson Disease (Parkinson's Disease) 06/2022
1	Wounds and Injuries (Trauma) 08/2021
1	Inflammation (Inflammations) 01/2020
1	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 02/2018
1	Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Restrictive Cardiomyopathy 01/2017
1	Cardiomyopathies (Cardiomyopathy) 12/2015
1	Glycogen Storage Disease Type II (Pompe's Disease) 06/2015
1	Nemaline Myopathies (Nemaline Myopathy) 05/2015
1	Cytochrome-c Oxidase Deficiency 12/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2014
1	Amyloid Neuropathies (Amyloid Neuropathy) 12/2013
1	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 12/2013
1	Pathological Protein Aggregation 03/2013
1	Dysferlinopathy 02/2013
1	Polymyositis 02/2013
1	Fibromyalgia (Fibrositis) 04/2011
1	Heart Failure 12/2010
1	Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy) 12/2010
1	Dyslipidemias (Dyslipidemia) 04/2010
1	Glycogen Storage Disease Type IV (Andersen's Disease) 11/2008
1	Rhabdomyolysis 10/2008
1	Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy) 12/2007

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 08/2021 - 08/2005
8	FilaminsIBA 06/2021 - 08/2005
5	DesminIBA 01/2013 - 05/2005
4	GlycogenIBA 01/2018 - 11/2002
4	Caveolin 3IBA 12/2003 - 07/2002
3	LipidsIBA 08/2021 - 10/2008
3	Protein AggregatesIBA 12/2019 - 01/2013
3	Nonsense Codon (Nonsense Mutation)IBA 02/2018 - 08/2005
3	Crystallins (Crystallin)IBA 01/2017 - 07/2005
3	CreatineIBA 06/2013 - 01/2002
3	DysferlinIBA 02/2007 - 04/2003
2	Biomarkers (Surrogate Marker)IBA 08/2021 - 08/2021
2	Myosins (Myosin)IBA 01/2017 - 05/2015
2	Mitochondrial DNA (mtDNA)IBA 03/2014 - 01/2007
2	Creatine Kinase (Creatine Phosphokinase)IBA 04/2010 - 07/2002
2	EnzymesIBA 12/2007 - 11/2002
1	alpha-SynucleinIBA 06/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022
1	CytokinesIBA 08/2021
1	GoldIBA 01/2021
1	Serum AlbuminIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2018
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2017
1	Valosin Containing ProteinIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2017
1	ConnectinIBA 01/2017
1	CalciumIBA 07/2015
1	Stromal Interaction Molecule 1IBA 07/2015
1	VimentinIBA 05/2015
1	nebulinIBA 05/2015
1	NestinIBA 05/2015
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 12/2014
1	beta-DefensinsIBA 01/2014
1	Prealbumin (Transthyretin)IBA 12/2013
1	SteroidsIBA 02/2013
1	deflazacortIBA 02/2013
1	Amyloid beta-PeptidesIBA 09/2011
1	polyglucosanIBA 11/2008
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2008
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 10/2008
1	emerinIBA 12/2007
1	LaminsIBA 12/2007

Therapy/Procedure

3	Therapeutics 01/2017 - 01/2002
2	Activities of Daily Living (ADL) 06/2013 - 02/2011
1	Resistance Training 10/2022
1	Enzyme Replacement Therapy 06/2015
1	Lasers (Laser) 01/2013
1	Transcranial Magnetic Stimulation 04/2011